FDA’s warning letter activity in the cosmetics space appeared to drop off steeply last fall, with not a peep from the agency for months, but newly published letters signal FDA’s continued surveillance of the marketplace for excessive claims on skin-care products.
Agency officials indicated last year in exchanges with lawmakers that the roughly 30 warning letters to skin-care companies in 2016 reflected an
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?